CEO Council for Growth | CGTCH

Leading Life Sciences Publications GEN News and Fierce Biotech Tell Greater Philadelphia’s Story

The Chamber's Select Greater Philadelphia initiative partnered with two leading trade publications to share news about the region's life sciences ecosystem and talent pool.

Learn more

Biomedical Technician Training Program Wins BioBuzz Workforce Champion Award

Biomedical Technician Training Program: Aseptic Manufacturing, a collaboration within Greater Philadelphia’s life sciences hub, has been honored by BioBuzz Media.

Learn more

MORE TO DISCOVER

Share the Greater Philadelphia Region’s success stories with the Chamber's Cell & Gene Therapy and Connected Health Initiative toolkit.

View the Toolkit

Scheer Partners reveals plans for $12M incubator called Center for Diagnostic Discovery in Horsham.

Kite acquires Tmunity Therapeutics to pursue next generation CAR T-Cell therapy advancements in cancer.

French biotech Sparing Vision’s lead gene therapy, SPVN06, receives IND clearance for treatment of retinitis pigmentosa.

Ocugen in Malvern announces OCU400 receives orphan drug designation for retinitis pigmentosa and Leber congenital amaurosis.

Cabaletta Bio in Philadelphia announces $35M public offering.

Stay Connected

Join The Mailing List

Thank you to our investors in the Cell & Gene Therapy and Connected Health Initiative:
Amerisource Bergen, Aramark, Children's Hospital of Philadelphia, ChristianaCare, Comcast, Drexel University, Independence Blue Cross, Jefferson Health, Macquarie Group, Penn Medicine, and University of Pennsylvania.

CEO COUNCIL FOR GROWTH
200 S. Broad Street, Suite 700 / Philadelphia, PA 19102 / CEOCouncilForGrowth.com

Click here to be removed from this list
This email was sent to the following email address: ??UserEmail??